Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jiangsu Senxuan Pharmaceutical CoBJSE:920946 86 Interest Coverage is 153.09 as of Jun. 2026, which is 53% above its 10-year median of 100.14. GuruFocus rates BJSE:920946 with a GF Score™ of 86/100 and a GF Value™ of ¥10.80 (Fairly Valued). The stock has 2 warning signs investors should review. Among 684 Drug Manufacturers companies, Jiangsu Senxuan Pharmaceutical Co ranks better than 93.42% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Jiangsu Senxuan Pharmaceutical Co's
Operating Income
for the
three
months ended in Jun. 2026 was ¥52.2 Mil. Jiangsu Senxuan Pharmaceutical Co's Interest Expense for the
three
months ended in Jun. 2026 was ¥-0.3 Mil.
Jiangsu Senxuan Pharmaceutical Co's interest coverage for the quarter that ended in Jun. 2026 was 153.09.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Jiangsu Senxuan Pharmaceutical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Jiangsu Senxuan Pharmaceutical Co's Interest Coverage or its related term are showing as below:
BJSE:920946'
s Interest Coverage Range Over the Past 10 Years
Min: 2.48 Med: 100.14 Max: 1617.51
Current: 425.46
BJSE:920946's Interest Coverage is ranked better than 93.42% of 684
companies
in the Drug Manufacturers industry
Industry Median: 13.035
vs BJSE:920946: 425.46
Jiangsu Senxuan Pharmaceutical Co (BJSE:920946) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Jiangsu Senxuan Pharmaceutical Co Interest Coverage Related Terms
Jiangsu Senxuan Pharmaceutical Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Jiangsu Senxuan Pharmaceutical Co Interest Coverage Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Senxuan Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Senxuan Pharmaceutical Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Senxuan Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Jiangsu Senxuan Pharmaceutical Co's Interest Coverage falls into.
Jiangsu Senxuan Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Senxuan Pharmaceutical Co (BJSE:920946) has a Interest Coverage of 153.09 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Jiangsu Senxuan Pharmaceutical Co and its competitors. This is 53% above median its historical median of 100.14. Over the past decade, Jiangsu Senxuan Pharmaceutical Co's Interest Coverage has ranged from 2.48 to 1,617.51. According to the industry distribution chart, Jiangsu Senxuan Pharmaceutical Co ranks #45 out of 684 companies in the Drug Manufacturers industry, placing it in the top 6.6%.
Is Jiangsu Senxuan Pharmaceutical Co's Interest Coverage too high?
Jiangsu Senxuan Pharmaceutical Co's current Interest Coverage of 153.09 is 53% above median its 10-year median of 100.14. Over the past 10 years, this metric has ranged from a low of 2.48 to a high of 1,617.51. The Drug Manufacturers industry median Interest Coverage is 13.04. Jiangsu Senxuan Pharmaceutical Co's value of 153.09 is 1074.5% above this industry median. Based on the distribution chart, Jiangsu Senxuan Pharmaceutical Co ranks #45 out of 684 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jiangsu Senxuan Pharmaceutical Co has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Senxuan Pharmaceutical Co's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Jiangsu Senxuan Pharmaceutical Co ranks #45 out of 684 companies for Interest Coverage. This places Jiangsu Senxuan Pharmaceutical Co in the top 7% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 13.04. Jiangsu Senxuan Pharmaceutical Co's value of 153.09 is 1074.5% above this benchmark. Historically, Jiangsu Senxuan Pharmaceutical Co's own Interest Coverage has ranged from 2.48 to 1,617.51 over the past decade. While the company's 10-year median is 100.14 vs. the industry median of 13.04, Jiangsu Senxuan Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 13.04, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Senxuan Pharmaceutical Co's current Interest Coverage of 153.09 is 1074.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Jiangsu Senxuan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 13.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Senxuan Pharmaceutical Co's current Interest Coverage is 153.09, which is 53% above median its own 10-year median of 100.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Senxuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Senxuan Pharmaceutical Co (BJSE:920946) is currently considered Fairly Valued. The stock's GF Value™ is ¥10.80, compared to a current price of ¥10.05 — trading 6.9% below its estimated fair value. The current Interest Coverage is 153.09, which is 53% above median its 10-year median of 100.14 and 1074.5% above the Drug Manufacturers industry median of 13.04. Jiangsu Senxuan Pharmaceutical Co's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Jiangsu Senxuan Pharmaceutical Co (BJSE:920946), the current Interest Coverage is 153.09 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Senxuan Pharmaceutical Co (BJSE:920946) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Senxuan Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥10.05 is trading 6.9% below its estimated GF Value™ of ¥10.80.
GuruFocus considers Jiangsu Senxuan Pharmaceutical Co to be Fairly Valued.
Key valuation signals for BJSE:920946:
Interest Coverage: 153.09 (53% above median its 10-year median of 100.14)
GF Value™: ¥10.80 vs. price of ¥10.05 (6.9% below fair value)
Industry Position: 1074.5% above the Drug Manufacturers median (#45 of 684)
No single metric tells the full story. See the BJSE:920946 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Senxuan Pharmaceutical Co Ltd is involved in the R&D, production, and sales of pharmaceutical intermediates and chemical intermediates. The company's main business is the research and development, production, and sales of raw materials and pharmaceutical intermediates.
86GF Score
Get the complete analysis for BJSE:920946
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920946 has been successfully added to your 
